$RNLXY 4 SEC Filings

Filed On	Filing
05 Nov 2024	Form 4: Icahn School Of Medicine At Mount Sinai, 10% owner and 3 others Acquired 13,366,750 shares (Other Transaction) ($1.55M)
13 Jun 2024	Form 4: Jung Joel R, Interim Chief Financial Office Granted 60,000 Employee Stock Option (right to buy)
26 Apr 2024	Form 4: Icahn School Of Medicine At Mount Sinai, 10% owner and 3 others Acquired 9,360,374 shares (Other Transaction) ($2.34M)
22 Nov 2023	Form 4: Coste Catherine, Director Granted 95,000 Employee Stock Option (right to buy)
22 Nov 2023	Form 4: Levangie Daniel J, Director Granted 95,000 Employee Stock Option (right to buy)
22 Nov 2023	Form 4: Parikh Chirag R., Director Granted 95,000 Employee Stock Option (right to buy)
22 Nov 2023	Form 4: Mills Christopher, Director Granted 95,000 Employee Stock Option (right to buy)
22 Nov 2023	Form 4: Doran Howard Jr, Chief Business Officer Granted 300,000 Employee Stock Option (right to buy)
11 Jul 2023	Form 4: Mclain Thomas H, President Granted 200,000 Employee Stock Option (right to buy)
07 Jul 2023	Form 4: Donovan Michael J., Chief Medical Officer Granted 85,731 Employee Stock Option (right to buy)
07 Jul 2023	Form 4: Coste Catherine, Director Granted 190,000 Employee Stock Option (right to buy)
07 Jul 2023	Form 4: McCullough James Renwick, Director Granted 875,017 Employee Stock Option (right to buy)
07 Jul 2023	Form 4: Mclain Thomas H, President Granted 394,486 Employee Stock Option (right to buy)
07 Jul 2023	Form 4: Fleming Fergus, Director Granted 352,902 Employee Stock Option (right to buy)
07 Jul 2023	Form 4: Sterling O. James, Chief Financial Officer Granted 575,160 Employee Stock Option (right to buy)

Comments